Biogen (BIIB) PT Lowered to $355 at Leerink Partners on Reduced Aducanumab Probability of Success
Go back to Biogen (BIIB) PT Lowered to $355 at Leerink Partners on Reduced Aducanumab Probability of Success| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 222.01 +2.94 (1.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $219.07 | 52 Week High | $333.65 | |||
| Open | $219.22 | 52 Week Low | $223.02 | |||
| Day High | $222.81 | P/E | 28.43 | |||
| Day Low | $219.00 | EPS | $7.81 | |||
| Volume | 50,527 | |||||

